Arch Biopartners Statistics

Total Valuation

Arch Biopartners has a market cap or net worth of CAD 125.36 million. The enterprise value is 130.76 million.

Market Cap	125.36M
Enterprise Value	130.76M

Important Dates

The next estimated earnings date is Tuesday, January 28, 2025.

Earnings Date	Jan 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.27%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	50.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-50.84
EV / Sales	92.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.20

Current Ratio	0.20
Quick Ratio	0.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.94

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-81.20%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.94
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +74.11% in the last 52 weeks. The beta is 1.39, so Arch Biopartners's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	+74.11%
50-Day Moving Average	1.88
200-Day Moving Average	1.78
Relative Strength Index (RSI)	50.68
Average Volume (20 Days)	21,847

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.14

Income Statement

In the last 12 months, Arch Biopartners had revenue of CAD 1.38 million and -2.57 million in losses. Loss per share was -0.04.

Revenue	1.38M
Gross Profit	-173,360
Operating Income	-1.92M
Pretax Income	-2.57M
Net Income	-2.57M
EBITDA	n/a
EBIT	-1.92M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 43,947 in cash and 5.32 million in debt, giving a net cash position of -5.28 million.

Cash & Cash Equivalents	43,947
Total Debt	5.32M
Net Cash	-5.28M
Net Cash Per Share	n/a
Equity (Book Value)	-6.56M
Book Value Per Share	-0.10
Working Capital	-6.06M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.72M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -12.53%, with operating and profit margins of -138.76% and -185.89%.

Gross Margin	-12.53%
Operating Margin	-138.76%
Pretax Margin	-185.89%
Profit Margin	-185.89%
EBITDA Margin	n/a
EBIT Margin	-138.76%
FCF Margin	n/a

Dividends & Yields

Arch Biopartners does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.27%
Shareholder Yield	-2.27%
Earnings Yield	-2.07%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Arch Biopartners has an Altman Z-Score of -28.4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-28.4
Piotroski F-Score	n/a